A. Visvikis - Concepedia

Author

A. Visvikis

Metaxa Hospital

Also Known As

A Visvikis, A. Visvikis, ANASTASIOS VISVIKIS, Anastasios Visvikis, Visvikis, Anastasios

Publications

537

Citations

H-Index

Concepts

All Affiliations

Metaxa Hospital Hospital Agioi Anargyroi National and Kapodistrian University of Athens Hippocration General Hospital University of Patras

About

A. Visvikis is an author at Metaxa Hospital specializing in cancer therapeutics, oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	199
2	Cancer Therapeutics	5	5	199
3	Pharmacology	3	3	65
4	Pathology	1	1	23
5	Surgical Oncology	1	1	97

A. Visvikis

Publications

485

Citations

H-Index

Page 1

	Year	Citations
Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone C. Christodoulou, A. Pervena, G. Klouvas, Oncology	2009	234
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03) Aristotelis Bamias, Urania Dafni, Alexandra Karadimou, Annals of Oncology Surgical OncologyUrologyHe 16/03Genitourinary CancerMedicine	2012	97
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group D. Pectasides, Gerasimos Aravantinos, Haralabos P. Kalofonos, Annals of Oncology Second-line TreatmentMetastatic Urothelial CancerUrologyCombination ChemotherapyGenitourinary Cancer	2001	37
Combination Chemotherapy With Carboplatin, Docetaxel, and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase II Study D. Pectasides, A. Aspropotamitis, A. Halikia, Journal of Clinical Oncology	1999	27
Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial Dimitrios Pectasides, A. Visvikis, A. Aspropotamitis, European Journal of Cancer UrologyOncologyPhase Ii TrialGenitourinary CancerMedicine	2000	26
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group. D. Pectasides, Haralabos P. Kalofonos, Epaminontas Samantas, PubMed PathologyPhase Ii StudyPharmacotherapyMetronomic ChemotherapyCancer Chemotherapy	2001	23
Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer D. Pectasides, A. Visvikis, Alexandros Kouloubinis, European Journal of Cancer Advanced Non-small-cell-lung CancerMedicinePharmacologyWeekly ChemotherapyBronchial Neoplasm	2002	16
Platinum-Based Chemotherapy of Primary Extragonadal Germ Cell Tumours: The Hellenic Cooperative Oncology Group Experience D. Pectasides, Gerasimos Aravantinos, A. Visvikis, Oncology	1999	13
<p>Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer</p> A. Visvikis, SM Kyvelou, P. Pietri, Cancer Management and Research	2020	12

Page 1